Results 191 to 200 of about 489,693 (333)

Efficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial

Arthritis &Rheumatology, Accepted Article.
Objective Despite availability of biologics and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, Yoshinori Taniguchi, Rosalía Martínez Pérez, Jaclyn Anderson, Ronilda D'Cunha, Weihan Zhao, Nicholas DeVogel, Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital   +13 more
wiley   +1 more source

The Relationship between Fine Particle Matter (PM2.5) Exposure and Upper Respiratory Tract Diseases. [PDF]

J Pers Med
Zaręba Ł, Piszczatowska K, Dżaman K, Soroczynska K, Motamedi P, Szczepański MJ, Ludwig N.   +6 more
europepmc   +1 more source

Upper Respiratory Tract Diseases in Athletes in Different Sports Disciplines. [PDF]

J Hum Kinet, 2016
Gałązka-Franta A, Jura-Szołtys E, Smółka W, Gawlik R.   +3 more
europepmc   +1 more source

Diagnosis and treatment of respiratory tract diseases.Recent advances.2.Diffusive lung diseases.2.Pulmonary fibrosis.

, 1993
山木戸 道郎
openalex   +2 more sources

Systemic autoimmune rheumatic disease risk is associated with long‐term exposure to fine particulate matter

Arthritis &Rheumatology, Accepted Article.
Objective Fine particulate matter (PM2.5) is a possible trigger of systemic autoimmune rheumatic diseases (SARDs). We investigated SARDs risk related to long‐term exposure to PM2.5 and its components (ammonium, black carbon, mineral dust, sea salt, nitrate, sulfate, organic matter), the composition of which may affect toxicity.
Mareva Geslin, Julien Vachon, Naizhuo Zhao, Elhadji Anassour Laouan Sidi, Sonia Jean, Audrey Smargiassi, Sasha Bernatsky   +6 more
wiley   +1 more source

Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood. [PDF]

Tissue Barriers, 2017
Yuksel H, Turkeli A.
europepmc   +1 more source

Human Metapneumovirus and Lower Respiratory Tract Disease in Children [PDF]

, 2004
N. Principi, Susanna Esposito, Samantha Bosis   +2 more
openalex   +1 more source

Guidelines for Respiratory Tract Diseases

Nihon Naika Gakkai Zasshi, 2009
openaire   +3 more sources

Advances in Small Molecule Inhibitors Targeting the Bacterial Lipoprotein Transport System (Lol) in Gram‐Negative Bacteria

Chemistry – An Asian Journal, EarlyView.
The lipoprotein transport system (Lol) is a crucial target for combating multidrug‐resistant gram‐negative bacteria. This review discusses the structural and functional aspects of the LolABCDE complex, recent advances in small‐molecule inhibitors, and challenges, such as permeability and resistance.
Saemee Song, Su Yong Shim
wiley   +1 more source

Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies. [PDF]

Microbiome, 2018
De Rudder C, Calatayud Arroyo M, Lebeer S, Van de Wiele T.   +3 more
europepmc   +1 more source